Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p‑Erk1/2/Nrf2/Trx/ASK1 signalling pathway in diabetic mice

Stitt AW, Lois N, Medina RJ, Adamson P and Curtis TM: Advances in our understanding of diabetic retinopathy. Clin Sci (Lond). 125:1–17. 2013. View Article : Google Scholar

Tarr JM, Kaul K, Chopra M, Kohner EM and Chibber R: Pathophysiology of diabetic retinopathy. ISRN Ophthalmol. 2013:3435602013.

Brownlee M: The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 54:1615–1625. 2005. View Article : Google Scholar : PubMed/NCBI

Laurent TC, Moore EC and Reichard P: Enzymatic synthesis of deoxyribonucleotides. Iv. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J Biol Chem. 239:3436–3444. 1964.PubMed/NCBI

Johnson J, Maher P and Hanneken A: The flavonoid, eriodictyol, induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase 2 gene expression. Invest Ophthalmol Vis Sci. 50:2398–2406. 2009. View Article : Google Scholar : PubMed/NCBI

Turgut F and Bolton WK: Potential new therapeutic agents for diabetic kidney disease. Am J Kidney Dis. 55:928–940. 2010. View Article : Google Scholar : PubMed/NCBI

Voziyan PA, Metz TO, Baynes JW and Hudson BG: A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J Biol Chem. 277:3397–3403. 2002. View Article : Google Scholar

Williams ME, Bolton WK, Khalifah RG, Degenhardt TP, Schotzinger RJ and McGill JB: Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol. 27:605–614. 2007. View Article : Google Scholar : PubMed/NCBI

Ruta LM, Magliano DJ, Lemesurier R, Taylor HR, Zimmet PZ and Shaw JE: Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countries. Diabetic Med. 30:387–398. 2013. View Article : Google Scholar : PubMed/NCBI

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2^−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar

Organisciak DT, Darrow RM, Barsalou L, Darrow RA, Kutty RK, Kutty G and Wiggert B: Light history and age-related changes in retinal light damage. Invest Ophthalmol Vis Sci. 39:1107–1116. 1998.PubMed/NCBI

Jain SK and Lim G: Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na⁺ + K⁺)-ATPase activity reduction in high glucose-treated human erythrocytes. Free Radic Biol Med. 30:232–237. 2001. View Article : Google Scholar : PubMed/NCBI

Marcucci R, Zanazzi M, Bertoni E, Rosati A, Fedi S, Lenti M, Prisco D, Castellani S, Abbate R and Salvadori M: Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients. Transplantation. 75:1551–1555. 2003. View Article : Google Scholar : PubMed/NCBI

Seger R and Krebs EG: The MAPK signaling cascade. FASEB J. 9:726–735. 1995.PubMed/NCBI

Raman M, Chen W and Cobb MH: Differential regulation and properties of MAPKs. Oncogene. 26:3100–3112. 2007. View Article : Google Scholar : PubMed/NCBI

Zhang W and Liu HT: MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 12:9–18. 2002. View Article : Google Scholar : PubMed/NCBI

Tan Y, Ichikawa T, Li J, Si Q, Yang H, Chen X, Goldblatt CS, Meyer CJ, Li X, Cai L and Cui T: Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo. Diabetes. 60:625–633. 2011. View Article : Google Scholar : PubMed/NCBI